Johan Nilsson

Johan Nilsson (MD, PhD) is a resident physician specializing in clinical pharmacology and has been working with CTC since 2020. He has experience as principal investigator and co-investigator in more than 50 clinical trials in all phases, including First-in-Human (FIH).

Johan has a special interest in psychiatry, in particular treatment of affective disorders, and education. He has a PhD in psychiatric epidemiology and he is a serving board member and chairman of KognioTM, a prominent Swedish centre for education and training in Cognitive Behavioral Therapy (CBT).

Latest publications

Agreement between self-reports, proxy-reports and the National Patient Register regarding diagnoses of cardiovascular disorders and diabetes mellitus in a population-based sample of 80-year-olds 21 June, 2019

The Gothenburg H70 Birth cohort study 2014-16: design, methods and study population 14 November, 2018

Changes in the expression of worries, anxiety, and generalized anxiety disorder with increasing age: A population study of 70 to 85-year-olds 25 October, 2018

NINE-YEAR FOLLOW-UP OF SPECIFIC PHOBIA IN A POPULATION SAMPLE OF OLDER PEOPLE 10 December, 2015

The 1-month prevalence of generalized anxiety disorder according to DSM-IV, DSM-V, and ICD-10 among nondemented 75-year-olds in Gothenburg, Sweden 3 May, 2012

Johan Nilsson

Latest publications

We provide our customers with cost-effective advice, conduct and reporting of clinical trials.